Robert Szasz

Debrecen, HB 4032, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Role of Autologous Haematopoietic Transplantation in Leukaemias: When to Consider It in 2026.

Role of Autologous Haematopoietic Transplantation in Leukaemias: When to Consider It in 2026.

Journal: Hematology reports

Published: June 09, 2026

Hodgkin Variant Richter's Transformation in the Absence of Classical Risk Factors: A Rare Case With Spinal Manifestation.

Hodgkin Variant Richter's Transformation in the Absence of Classical Risk Factors: A Rare Case With Spinal Manifestation.

Journal: Cureus

Published: February 13, 2026

Resistance mechanisms and clonal dynamics in mantle cell lymphoma treated with sequential BTKi and venetoclax therapy.

Resistance mechanisms and clonal dynamics in mantle cell lymphoma treated with sequential BTKi and venetoclax therapy.

Journal: The Journal of pathology

Published: January 07, 2025

The efficacy and safety of second salvage autologous transplantation in myeloma patients.

The efficacy and safety of second salvage autologous transplantation in myeloma patients.

Journal: Pathology oncology research : POR

Published: May 27, 2024

Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.

Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.

Journal: The journal of pathology. Clinical research

Published: July 26, 2023

Autologous Transplantation May Still Effectively Treat Relapsed Diffuse Large B-Cell Lymphoma in Selected Patients.

Autologous Transplantation May Still Effectively Treat Relapsed Diffuse Large B-Cell Lymphoma in Selected Patients.

Journal: Cancers

Published: May 21, 2023

Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax.

Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax.

Journal: International journal of molecular sciences

Published: February 02, 2023

Circulating microRNA sequencing revealed miRNome patterns in hematology and oncology patients aiding the prognosis of invasive aspergillosis.

Circulating microRNA sequencing revealed miRNome patterns in hematology and oncology patients aiding the prognosis of invasive aspergillosis.

Journal: Scientific reports

Published: September 09, 2021

Ibrutinib-induced acute kidney injury via interstitial nephritis.

Ibrutinib-induced acute kidney injury via interstitial nephritis.

Journal: Renal failure

Published: February 11, 2021

Screening and monitoring of the BTKC481S mutation in a real-world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy.

Screening and monitoring of the BTKC481S mutation in a real-world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy.

Journal: British journal of haematology

Published: January 25, 2021

Fludarabine-Cyclophosphamide-Rituximab Treatment in Chronic Lymphocytic Leukemia, Focusing on Long Term Cytopenias Before and After the Era of Targeted Therapies.

Fludarabine-Cyclophosphamide-Rituximab Treatment in Chronic Lymphocytic Leukemia, Focusing on Long Term Cytopenias Before and After the Era of Targeted Therapies.

Journal: Pathology oncology research : POR

Published: January 07, 2021

Interdisciplinary approach to the current management of chronic lymphocytic leukemia

Interdisciplinary approach to the current management of chronic lymphocytic leukemia

Journal: Orvosi hetilap

Published: June 10, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026